RTL8C
gene geneOn this page
Also known as Mart8Mar8MAR8CSIRH5
Summary
RTL8C (retrotransposon Gag like 8C, HGNC:2569) is a protein-coding gene on chromosome Xq26.3, encoding Retrotransposon Gag-like protein 8C (A6ZKI3).
Predicted to be located in plasma membrane.
Source: NCBI Gene 8933 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 3 total
- MANE Select transcript:
NM_001078171
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:2569 |
| Approved symbol | RTL8C |
| Name | retrotransposon Gag like 8C |
| Location | Xq26.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | Mart8, Mar8, MAR8C, SIRH5 |
| Ensembl gene | ENSG00000134590 |
| Ensembl biotype | protein_coding |
| OMIM | 300213 |
| Entrez | 8933 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 2 protein_coding_CDS_not_defined, 1 protein_coding
ENST00000257013, ENST00000464369, ENST00000495563
RefSeq mRNA: 1 — MANE Select: NM_001078171
NM_001078171
CCDS: CCDS43997
Canonical transcript exons
ENST00000257013 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000921629 | 135032355 | 135033546 |
Expression profiles
Bgee: expression breadth ubiquitous, 292 present calls, max score 99.53.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 216.9141 / max 2438.9187, expressed in 1800 samples.
FANTOM5 promoters (5 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 197621 | 189.7396 | 1799 |
| 197620 | 20.0912 | 1757 |
| 197624 | 3.3872 | 1178 |
| 197622 | 2.5028 | 1145 |
| 197623 | 1.1933 | 776 |
Top tissues by expression
293 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| Brodmann (1909) area 10 | UBERON:0013541 | 99.53 | gold quality |
| frontal pole | UBERON:0002795 | 99.45 | gold quality |
| right frontal lobe | UBERON:0002810 | 99.34 | gold quality |
| prefrontal cortex | UBERON:0000451 | 99.31 | gold quality |
| hypothalamus | UBERON:0001898 | 99.30 | gold quality |
| apex of heart | UBERON:0002098 | 99.27 | gold quality |
| cingulate cortex | UBERON:0003027 | 99.27 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 99.27 | gold quality |
| amygdala | UBERON:0001876 | 99.21 | gold quality |
| nucleus accumbens | UBERON:0001882 | 99.17 | gold quality |
| heart left ventricle | UBERON:0002084 | 99.16 | gold quality |
| cardiac ventricle | UBERON:0002082 | 99.15 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 99.15 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 99.14 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 99.13 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 99.12 | gold quality |
| frontal cortex | UBERON:0001870 | 99.10 | gold quality |
| adenohypophysis | UBERON:0002196 | 99.08 | gold quality |
| caudate nucleus | UBERON:0001873 | 99.04 | gold quality |
| spinal cord | UBERON:0002240 | 99.04 | gold quality |
| right coronary artery | UBERON:0001625 | 99.02 | gold quality |
| right atrium auricular region | UBERON:0006631 | 99.01 | gold quality |
| temporal lobe | UBERON:0001871 | 98.99 | gold quality |
| lateral nuclear group of thalamus | UBERON:0002736 | 98.99 | gold quality |
| left coronary artery | UBERON:0001626 | 98.98 | gold quality |
| neocortex | UBERON:0001950 | 98.98 | gold quality |
| cardiac atrium | UBERON:0002081 | 98.97 | gold quality |
| middle frontal gyrus | UBERON:0002702 | 98.97 | gold quality |
| coronary artery | UBERON:0001621 | 98.95 | gold quality |
| lower esophagus | UBERON:0013473 | 98.94 | gold quality |
Single-cell (SCXA)
Detected in 7 experiment(s), a significant marker in 4.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-10042 | yes | 11.48 |
| E-HCAD-25 | yes | 7.39 |
| E-CURD-112 | yes | 6.57 |
| E-MTAB-7303 | no | 650.53 |
| E-MTAB-7052 | no | 202.47 |
| E-MTAB-6678 | no | 3.64 |
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
44 targeting RTL8C, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3925-3P | 100.00 | 69.95 | 1237 |
| HSA-MIR-7152-3P | 99.97 | 67.47 | 849 |
| HSA-MIR-6825-5P | 99.96 | 69.81 | 3431 |
| HSA-MIR-651-3P | 99.94 | 73.48 | 5177 |
| HSA-MIR-6753-3P | 99.93 | 66.57 | 637 |
| HSA-MIR-7107-3P | 99.93 | 66.73 | 627 |
| HSA-MIR-515-5P | 99.92 | 69.82 | 2343 |
| HSA-MIR-519E-5P | 99.92 | 69.62 | 2358 |
| HSA-MIR-124-3P | 99.89 | 73.74 | 3043 |
| HSA-MIR-506-3P | 99.89 | 73.55 | 3057 |
| HSA-MIR-3919 | 99.87 | 69.45 | 2489 |
| HSA-MIR-4728-5P | 99.85 | 69.39 | 4718 |
| HSA-MIR-6785-5P | 99.82 | 68.68 | 4428 |
| HSA-MIR-92A-2-5P | 99.75 | 67.01 | 2164 |
| HSA-MIR-149-3P | 99.72 | 68.22 | 3963 |
| HSA-MIR-6883-5P | 99.69 | 68.05 | 3785 |
| HSA-MIR-4729 | 99.69 | 72.18 | 4233 |
| HSA-MIR-142-3P | 99.62 | 71.30 | 974 |
| HSA-MIR-4756-3P | 99.62 | 66.30 | 1319 |
| HSA-MIR-1249-5P | 99.61 | 66.55 | 2049 |
| HSA-MIR-6797-5P | 99.61 | 66.55 | 2084 |
| HSA-MIR-892A | 99.54 | 68.16 | 1141 |
| HSA-MIR-7106-5P | 99.53 | 67.47 | 3574 |
| HSA-MIR-766-3P | 99.47 | 65.24 | 1811 |
| HSA-MIR-766-5P | 99.47 | 67.91 | 2225 |
| HSA-MIR-6722-3P | 99.45 | 67.62 | 1919 |
| HSA-MIR-3960 | 99.41 | 66.11 | 96 |
| HSA-MIR-6719-3P | 99.29 | 67.78 | 1387 |
| HSA-MIR-5582-5P | 99.27 | 71.42 | 1879 |
| HSA-MIR-6868-5P | 99.06 | 65.69 | 1284 |
Literature-anchored findings (GeneRIF, showing 3)
- Sequence-Selective Covalent CaaX-Box Receptors Prevent Farnesylation of Oncogenic Ras Proteins and Impact MAPK/PI3 K Signaling. (PMID:33899342)
- Evaluation of expression level and methylation profile of CXX1 gene in breast cancer tissue blocks. (PMID:34916361)
- RTL8 promotes nuclear localization of UBQLN2 to subnuclear compartments associated with protein quality control. (PMID:35247097)
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Rtl8c | ENSMUSG00000051851 |
| mus_musculus | Rtl8b | ENSMUSG00000067924 |
| mus_musculus | Rtl8a | ENSMUSG00000067925 |
| rattus_norvegicus | Rtl8a | ENSRNOG00000062466 |
Paralogs (10): RTL3 (ENSG00000179300), LDOC1 (ENSG00000182195), RTL4 (ENSG00000187823), RTL6 (ENSG00000188636), RTL8A (ENSG00000203950), RTL8B (ENSG00000212747), RTL10 (ENSG00000215012), PEG10 (ENSG00000242265), RTL5 (ENSG00000242732), RTL1 (ENSG00000254656)
Protein
Protein identifiers
Retrotransposon Gag-like protein 8C — A6ZKI3 (reviewed: A6ZKI3, O15255)
Alternative names: Mammalian retrotransposon derived protein 8C
All UniProt accessions (1): A6ZKI3
UniProt curated annotations — full annotation on UniProt →
Miscellaneous. RTL8C is one of at least 11 genes called Mar or Mart related to long terminal repeat retrotransposons. They do not correspond to functional retrotransposons, but rather to neofunctionalized retrotransposons genes.
Similarity. Belongs to the FAM127 family.
RefSeq proteins (1): NP_001071639* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR032549 | RTL1/1-8/LDOC_capsid-like | Domain |
| IPR031771 | CAAX_1 | Family |
Pfam: PF15895, PF16297
UniProt features (8 total): chain 2, sequence variant 2, propeptide 1, region of interest 1, modified residue 1, lipid moiety-binding region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A6ZKI3-F1 | 89.00 | 0.71 |
| AF-O15255-F1 | 36.51 | 0.00 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (2): 206, 206
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 115 (showing top):
MULLIGHAN_NPM1_SIGNATURE_3_UP, TIEN_INTESTINE_PROBIOTICS_24HR_UP, FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN, SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1A, CHEN_HOXA5_TARGETS_9HR_DN, ACEVEDO_LIVER_CANCER_UP, LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP, CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN, BLALOCK_ALZHEIMERS_DISEASE_DN, ZHENG_GLIOBLASTOMA_PLASTICITY_UP, STEIN_ESRRA_TARGETS_UP, MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP, KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_UP, KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_UP, KIM_ALL_DISORDERS_CALB1_CORR_UP
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (1): plasma membrane (GO:0005886)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
| membrane | 1 |
| cell periphery | 1 |
Protein interactions and networks
STRING
666 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| RTL8C | RTL4 | Q6ZR62 | 675 |
| RTL8C | RTL5 | Q5HYW3 | 672 |
| RTL8C | RTL9 | Q8NET4 | 606 |
| RTL8C | CLLU1-AS1 | Q5K130 | 433 |
| RTL8C | IHO1 | Q8IYA8 | 366 |
| RTL8C | TCAF1 | Q9Y4C2 | 364 |
| RTL8C | MCRIP2 | Q9BUT9 | 360 |
| RTL8C | MOSPD1 | Q9UJG1 | 315 |
| RTL8C | SEZ6L | Q9BYH1 | 306 |
| RTL8C | PPID | Q08752 | 306 |
| RTL8C | TCEAL2 | Q9H3H9 | 299 |
| RTL8C | H0YL38 | H0YL38 | 290 |
| RTL8C | RABEPK | Q7Z6M1 | 287 |
| RTL8C | ZNF280D | Q6N043 | 285 |
| RTL8C | ZCCHC3 | Q9NUD5 | 284 |
IntAct
92 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| RTL8C | UBQLN1 | psi-mi:“MI:0915”(physical association) | 0.720 |
| UBQLN1 | RTL8C | psi-mi:“MI:0915”(physical association) | 0.720 |
| PEG10 | RTL8C | psi-mi:“MI:0914”(association) | 0.700 |
| RTL8C | PEG10 | psi-mi:“MI:0915”(physical association) | 0.700 |
| RTL8C | PEG10 | psi-mi:“MI:0915”(physical association) | 0.670 |
| PEG10 | RTL8C | psi-mi:“MI:0915”(physical association) | 0.670 |
| PEG10 | RTL8C | psi-mi:“MI:0914”(association) | 0.670 |
| UBQLN1 | RTL8C | psi-mi:“MI:0915”(physical association) | 0.560 |
| RTL8C | UBQLN1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| RTL8C | UBQLN2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| RTL8C | REL | psi-mi:“MI:0915”(physical association) | 0.560 |
| RTL8C | GPANK1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| RTL8C | CDKN2B | psi-mi:“MI:0915”(physical association) | 0.560 |
| RTL8C | LMO2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| RTL8C | CCDC102B | psi-mi:“MI:0915”(physical association) | 0.560 |
| RTL8C | SAMD11 | psi-mi:“MI:0915”(physical association) | 0.560 |
| C3AR1 | TMEM120B | psi-mi:“MI:0914”(association) | 0.530 |
| SLC15A1 | METTL15 | psi-mi:“MI:0914”(association) | 0.530 |
| OTC | RTL8C | psi-mi:“MI:0914”(association) | 0.530 |
| NPY2R | RTL8C | psi-mi:“MI:0914”(association) | 0.530 |
| THTPA | RTL8C | psi-mi:“MI:0914”(association) | 0.530 |
BioGRID (73): PEG10 (Two-hybrid), UBQLN1 (Two-hybrid), FAM127A (Affinity Capture-MS), FAM127A (Affinity Capture-MS), FAM127A (Affinity Capture-MS), FAM127A (Affinity Capture-MS), FAM127A (Affinity Capture-MS), FAM127A (Affinity Capture-MS), FAM127A (Affinity Capture-MS), FAM127A (Affinity Capture-MS), FAM127A (Affinity Capture-MS), FAM127A (Affinity Capture-MS), FAM127A (Affinity Capture-MS), FAM127A (Affinity Capture-MS), FAM127A (Affinity Capture-MS)
ESM2 similar proteins: A6QLK5, A6ZKI3, D2HBJ8, O15519, O94955, O95751, P0CW24, P10272, Q0V9G5, Q17QF6, Q17RB0, Q1JQ94, Q2TBA3, Q5RD56, Q5RER6, Q5XGZ2, Q63053, Q6NTR6, Q6P5G6, Q6SEH4, Q6SEH5, Q70Z35, Q7JV70, Q7K1U0, Q7LC44, Q7TPY9, Q86TG7, Q8AWC3, Q8C1C8, Q8CA95, Q8N165, Q8N635, Q8ND90, Q8QZR7, Q8TCU6, Q8VHZ4, Q8WNV3, Q96PV4, Q9BWD3, Q9BYG7
Diamond homologs: A6NKG5, A6ZKI3, O95751, Q17QF6, Q17RB0, Q1JQ94, Q52QI2, Q5DTZ0, Q5HYW3, Q6SEH4, Q6SEH5, Q7M732, Q7TPY9, Q9BWD3, Q505G4, Q6ICC9, Q7TN75, Q86TG7, Q8N8U3, Q32KG4, Q5DTT4, Q5R6M8, Q7L3V2, Q6P1Y1
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
3 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 3 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
188 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| X:135032643:A:T | donor_gain | 0.9900 |
| X:135032708:G:GT | donor_gain | 0.9800 |
| X:135032730:G:GT | donor_gain | 0.9800 |
| X:135032711:G:GT | donor_gain | 0.9700 |
| X:135032690:C:T | donor_gain | 0.9600 |
| X:135032717:G:GT | donor_gain | 0.9400 |
| X:135032638:G:GT | donor_gain | 0.9300 |
| X:135032616:A:AG | donor_gain | 0.9200 |
| X:135032617:G:GG | donor_gain | 0.9200 |
| X:135032624:A:AG | donor_gain | 0.9100 |
| X:135032686:G:GT | donor_gain | 0.8600 |
| X:135032642:G:GT | donor_gain | 0.8500 |
| X:135032704:G:GT | donor_gain | 0.8400 |
| X:135032705:G:T | donor_gain | 0.7700 |
| X:135032700:G:GT | donor_gain | 0.7400 |
| X:135032726:G:GT | donor_gain | 0.7300 |
| X:135032684:A:G | donor_gain | 0.7100 |
| X:135032730:G:T | donor_gain | 0.6800 |
| X:135032727:C:T | donor_gain | 0.6700 |
| X:135032731:G:GT | donor_gain | 0.6400 |
| X:135032573:A:T | donor_gain | 0.6300 |
| X:135032571:TGAAG:T | donor_loss | 0.6000 |
| X:135032572:GAAGG:G | donor_loss | 0.6000 |
| X:135032573:AAG:A | donor_loss | 0.6000 |
| X:135032574:AGGT:A | donor_loss | 0.6000 |
| X:135032575:G:C | donor_loss | 0.6000 |
| X:135032576:G:T | donor_loss | 0.6000 |
| X:135032577:T:A | donor_loss | 0.6000 |
| X:135032705:G:GT | donor_gain | 0.6000 |
| X:135032689:G:GG | donor_gain | 0.5900 |
AlphaMissense
738 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1002500077 (X:135032061 T>C), RS1005620804 (X:135033979 T>C), RS1006304346 (X:135031980 G>C,T), RS1006397701 (X:135031373 A>G), RS1007148345 (X:135032811 C>G,T), RS1007559937 (X:135030831 G>A,C), RS1007943245 (X:135030373 G>A), RS1008124276 (X:135030906 A>G), RS1008570047 (X:135030743 C>A,T), RS1009339972 (X:135031202 G>A), RS1010564631 (X:135032579 A>G), RS1011212743 (X:135033687 A>G), RS1011973149 (X:135031504 T>A), RS1012829950 (X:135032296 G>A,C), RS1015953125 (X:135030909 G>A)
Disease associations
OMIM: gene MIM:300213 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
25 total (human), top 25 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Tetrachlorodibenzodioxin | increases expression | 2 |
| Aflatoxin B1 | increases expression, decreases methylation | 2 |
| sodium arsenite | increases abundance, increases expression | 1 |
| manganese chloride | increases abundance, increases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| MT19c compound | decreases expression | 1 |
| Resveratrol | affects cotreatment, increases expression | 1 |
| Temozolomide | decreases expression | 1 |
| Arsenic | increases abundance, increases expression | 1 |
| Benzo(a)pyrene | increases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Fluorouracil | affects response to substance | 1 |
| Ivermectin | decreases expression | 1 |
| Manganese | increases abundance, increases expression | 1 |
| Plant Extracts | affects cotreatment, increases expression | 1 |
| Potassium Dichromate | increases expression | 1 |
| Smoke | decreases expression | 1 |
| Thimerosal | decreases expression | 1 |
| Thiram | decreases expression | 1 |
| Tobacco Smoke Pollution | affects expression | 1 |
| Tunicamycin | decreases expression | 1 |
| Valproic Acid | increases expression | 1 |
| Vitamin E | increases expression | 1 |
| Antirheumatic Agents | increases expression | 1 |
| Acrylamide | decreases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_B3GD | Abcam HEK293T RTL8C KO | Transformed cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.